—

Tempus AI, Inc. Class A Common Stock(TEM)— 同类公司组

数据截至2026-11-20 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Tempus AI, Inc. Class A Common Stock的Closelook综合评分为40/100,在同类公司组内排名第9位(共9家)——组内评分最高的是Halozyme Therapeutics Inc(72/100)。

名称综合动量质量估值信号距52周高点
TEM Tempus AI, Inc. Class A Common Stock40652017bear38.7%
HQY HealthEquity Inc62687041info14.1%
VEEV Veeva Systems Inc Class A60867527bear19.3%
HNGE Hinge Health, Inc.57916822info16.3%
BTSG BrightSpring Health Services, Inc. Common Stock50772936ok14.8%
HALO Halozyme Therapeutics Inc72679451info31.8%
ONC BeOne Medicines AG66886829ok8%
REGN Regeneron Pharmaceuticals Inc65897346watch7%
ANN.AU Ansell Ltd64964750ok2.7%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-11-20

Quick answers

Tempus AI, Inc. Class A Common Stock在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:HealthEquity Inc (HQY)、Veeva Systems Inc Class A (VEEV)、Hinge Health, Inc. (HNGE)、BrightSpring Health Services, Inc. Common Stock (BTSG)、Halozyme Therapeutics Inc (HALO)、BeOne Medicines AG (ONC)、Regeneron Pharmaceuticals Inc (REGN)、Ansell Ltd (ANN.AU)。

TEM相对同类公司的评分如何?

Tempus AI, Inc. Class A Common Stock的综合评分为40/100,组内排名第9位(共9家),截至2026-11-20;组内最高综合评分为Halozyme Therapeutics Inc(72/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.